Back
Stoke Therapeutics, Inc. Stock Predictions
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
61
STOK
Stoke Therapeutics, Inc.
Last Price:
$31.98
Seasonality Move:
-3.69%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiStoke Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.2% based on the past 6 years of stock performance.
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Stoke Therapeutics, Inc. Stock Undervalued?The current Stoke Therapeutics, Inc. [STOK] share price is $32.86. The Score for STOK is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 42.2% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. Stock Rating
Buy
61
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. overpriced?
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Stoke Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
38.69
52-Week Low:
5.35
Prediction Charts
Market Cap:
1.9B
Price in USD:
32.86
Volume:
852K
Beta:
0.95
Technical Analysis
SMA50:
30.14
SMA100:
24.96
SMA200:
17.37
52-Wk Change:
171.57%
Stock Predictions
-
Is Stoke Therapeutics, Inc. stock public?Yes, Stoke Therapeutics, Inc. is a publicly traded company.
-
What is the Stoke Therapeutics, Inc. stock quote today?The Stoke Therapeutics, Inc. stock price is 32.86 USD today.
-
How to buy Stoke Therapeutics, Inc. stock online?You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 31.22 | 30.91 | 31.44 | 30.28 |
| Dec-1 | 30.73 | 30.09 | 30.73 | 29.32 |
| Dec-2 | 29.80 | 29.81 | 30.71 | 28.74 |
| Dec-3 | 29.81 | 30.96 | 31.23 | 29.70 |
| Dec-4 | 30.23 | 31.05 | 31.54 | 30.10 |
| Dec-5 | 31.13 | 30.87 | 32.09 | 30.26 |
| Dec-8 | 31.29 | 33.00 | 33.30 | 30.90 |
| Dec-9 | 32.73 | 30.47 | 33.34 | 30.37 |
| Dec-10 | 31.11 | 34.15 | 35.34 | 30.17 |
| Dec-11 | 33.85 | 33.09 | 35.40 | 32.93 |
| Dec-12 | 33.33 | 32.39 | 33.77 | 32.26 |
| Dec-15 | 33.13 | 32.98 | 35.43 | 32.47 |
| Dec-16 | 32.52 | 33.61 | 33.93 | 32.40 |
| Dec-17 | 33.60 | 32.86 | 34.05 | 32.43 |
Stoke Therapeutics, Inc. Earnings
Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics, Inc. Forecast Revenue Growth
Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.